1-(4-Chloro-2,6-difluorophenyl)piperidin-4-one, 98%, 50mg

p-xilene, min 99%, per sintesi, 500 ml, confezione in vetro

2-Bromo-6-methoxynicotinic acid, 95%, 5g

N-METHYL(MORPHOLIN-2-YL)METHANAMINE, 95.0%, 100mg

(S)-2-(3-Chlorophenyl)pyrrolidine hydrochloride, 95.0%, 250mg

(R)-Cyclopropyl(4-methoxyphenyl)methanamine hydrochloride, 95.0%, 1g

4-allyl-5-[(2-chloro-5-methylphenoxy)methyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

tert-Butyl 2-amino-4-oxo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate, 97%, 250mg

3-Isopropenylpyridine, 95% mix TBC as stabilizer, 1g

2-Methoxy-3-(trifluoromethyl)aniline, 95.0%, 10g

6-Bromo-2-chloroquinoxaline, 95.0%, 25g

2-[(tert-Butoxy)carbonyl]-5-oxa-2-azaspiro[3.4]octane-6-carboxylic acid, 95+%, 5g

Methyl 3-amino-5-chloro-2-methylbenzoate, 95.0%, 1g